Therapy Areas: Diabetes
Dexcom launches Dexcom Flex CGM system for Type 2 diabetes patients in Germany
18 May 2026 - Biosensing technology company DexCom Inc (Nasdaq: DXCM) announced on Monday that it has introduced Dexcom Flex, a new continuous glucose monitoring system designed for adults with Type 2...
Apotex announces commercial launch of Apo-Semaglutide Injection in Canada
15 May 2026 - Apotex Inc, a Canada-based global health company, announced on Thursday the commercial launch in Canada of Apo-Semaglutide Injection, a generic equivalent of Ozempic.The product will be ...
Bayer to acquire Perfuse Therapeutics in USD2.45bn deal to expand ophthalmology pipeline
6 May 2026 - German pharmaceutical and life sciences company Bayer AG (ETR:BAYN) (OTC:BAYRY) announced on Wednesday that it has agreed to fully acquire Perfuse Therapeutics Inc, strengthening its phar...
ZYUS Life Sciences receives second US pain management patent
6 May 2026 - Canada-based ZYUS Life Sciences Corporation (TSXV:ZYUS), a clinical-stage life sciences company focused on the development and commercialisation of novel non-opioid drug candidates for pa...
Apotex receives Health Canada approval for a generic Ozempic equivalent
4 May 2026 - Apotex Inc, a Canada-based global health company, announced on Friday that Health Canada has approved Apo-Semaglutide InjectionTM, a generic equivalent of Ozempic (semaglutide injection)....
Spinogenix to present tazbentetol preclinical results in glaucoma and diabetic retinopathy models at ARVO 2026
4 May 2026 - Spinogenix Inc, a California-based clinical-stage biopharmaceutical company announced on Sunday that it will present the results of two new preclinical studies demonstrating the neuroprot...